Psychedelics Archives - Page 32 of 68

1 minute read

Red Light Holland Releases Report On Psilocybin Microdosing In Collaboration With NUBU Pharmaceuticals

April 26, 9:54 AM

Red Light Holland Corp. (OTCQB: TRUFF) (CSE:TRIP) (FSE:4YX) has in collaboration with NUBU Pharmaceutical, published a report aimed at educating law makers and a network of medical doctors in Australasia, about the potential benefits of microdosing psilocybin

CSE:TRIP

2 minute read

Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed

By Lara Goldstein

April 25, 4:32 PM

Reunion Neuroscience (NASDAQ: REUN) no longer meets the minimum required $1.00 per-common-share for continued listing on the Nasdaq.

REUN

2 minute read

New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings

By Lara Goldstein

April 25, 4:19 PM

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) is advancing the development of its novel compounds family of next-gen MDMA analogs. So far, Mydecine's compounds show promising pharmacokinetics (PK) and pharmacodynamics (PD) in preclinical models.

MYCOF

2 minute read

Mia Khalifa Joins Magic Mushrooms Company, Here’s What She’ll Be Doing

By Lara Goldstein

April 25, 3:58 PM

Canada-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) has launched a collaboration with former adult film performer and social media star Mia Khalifa.

TRUFF

2 minute read

New Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market

By Lara Goldstein

April 25, 1:30 PM

Psychedelics developer PharmAla Biotech continues to provide its Good Manufacturing Practices (GMP)-compliant psychedelics to Australian-based businesses developing clinical trials and, soon, actual treatments with the substances.

IXHL

3 minute read

Psyched: LSD For Major Depression, Canada’s Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More

By Lara Goldstein

April 24, 3:57 PM

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).

AWKNF

2 minute read

Core One’s Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of Psilocin

By Vuk Zdinjak

April 24, 10:26 AM

Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN:A3CSSU) announced that its wholly-owned subsidiary, Awakened Biosciences Inc.

CLABF

2 minute read

Red Light Holland Receives Certificate Of Analysis For Their Dehydrated Homogenized Natural Psilocybin Aimed For Distribution In Australasia

By Vuk Zdinjak

April 21, 9:21 AM

Red Light Holland Corp. (CSE:TRIP) (FSE:4YX) (OTCQB: TRUFF) announced updates regarding its manufacturing plans to create homogenized natural psilocybin microdosing capsules.

CSE:TRIP

1 minute read

SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression

By Vuk Zdinjak

April 21, 9:12 AM

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that as part of its ongoing collaboration with Clearmind Medicine Inc. (NASDAQ:

CMND

2 minute read

EXCLUSIVE: Fireside With Enveric Biosciences’s Dr. Tucker, Unlocking Psychedelic Healing Benefits

By Joana Scopel

April 20, 5:02 PM

Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine.

ENVB